Compare · IFF vs IOSP
IFF vs IOSP
Side-by-side comparison of International Flavors & Fragrances Inc. (IFF) and Innospec Inc. (IOSP): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both IFF and IOSP operate in Major Chemicals (Industrials), so they compete in similar markets.
- IFF is the larger of the two at $18.64B, about 9.4x IOSP ($1.99B).
- Over the past year, IFF is down 7.1% and IOSP is down 7.3% - IFF leads by 0.3 points.
- IFF has been more active in the news (4 items in the past 4 weeks vs 2 for IOSP).
- IFF has more recent analyst coverage (25 ratings vs 2 for IOSP).
- Company
- International Flavors & Fragrances Inc.
- Innospec Inc.
- Price
- $72.72-0.40%
- $81.39+0.37%
- Market cap
- $18.64B
- $1.99B
- 1M return
- -7.05%
- +6.27%
- 1Y return
- -7.06%
- -7.33%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 4
- 2
- Recent ratings
- 25
- 2
International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers flavor compounds; savory solutions, such as marinades or powder blends of flavors, natural colors, seasonings, functional ingredients, and natural anti-oxidants; and inclusions. It also provides nutrition and specialty ingredients primarily consist of natural health ingredients, natural food protection products, and natural colors and flavor ingredients. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and alginates-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Innospec Inc.
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. It operates through Fuel Specialties, Performance Chemicals, and Oilfield Services segments. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and maintain asset integrity. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Latest IFF
- Director Fribourg Paul J bought $20,317,854 worth of shares (273,500 units at $74.29), increasing direct ownership by 46% to 43,150 units (SEC Form 4)
- SEC Form 8-K filed by International Flavors & Fragrances Inc.
- IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC
- LMR by IFF Inaugurates New Experimental Field in Grasse
- IFF Opens Vanilla Innovation Center in Madagascar
- LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery
- President, Scent Teles De Mendonca Ana Paula converted options into 708 shares and covered exercise/tax liability with 362 shares, increasing direct ownership by 6% to 5,718 units (SEC Form 4)
- EVP, Global Operations Officer Finzel Ralf converted options into 1,326 shares and covered exercise/tax liability with 734 shares, increasing direct ownership by 3% to 17,621 units (SEC Form 4)
- EVP, CFO Deveau Michael converted options into 884 shares and covered exercise/tax liability with 452 shares, increasing direct ownership by 3% to 14,024 units (SEC Form 4)
- EVP, Chief Ppl&Culture Officer Borg Deborah converted options into 1,768 shares and covered exercise/tax liability with 713 shares, increasing direct ownership by 3% to 37,925 units (SEC Form 4)
Latest IOSP
- Innospec Inc. filed SEC Form 8-K: Leadership Update
- SEC Form SD filed by Innospec Inc.
- Innospec Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 10-Q filed by Innospec Inc.
- Innospec Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Innospec Reports First Quarter 2026 Financial Results
- Innospec Schedules First Quarter 2026 Earnings Release and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Innospec Inc.
- SEC Form DEFA14A filed by Innospec Inc.
- SEC Form DEF 14A filed by Innospec Inc.